1. Home
  2. SMWB vs NUVB Comparison

SMWB vs NUVB Comparison

Compare SMWB & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMWB
  • NUVB
  • Stock Information
  • Founded
  • SMWB 2007
  • NUVB 2018
  • Country
  • SMWB Israel
  • NUVB United States
  • Employees
  • SMWB N/A
  • NUVB N/A
  • Industry
  • SMWB Computer Software: Programming Data Processing
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMWB Technology
  • NUVB Health Care
  • Exchange
  • SMWB Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • SMWB 857.2M
  • NUVB 1.1B
  • IPO Year
  • SMWB 2021
  • NUVB N/A
  • Fundamental
  • Price
  • SMWB $9.86
  • NUVB $3.23
  • Analyst Decision
  • SMWB Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • SMWB 9
  • NUVB 6
  • Target Price
  • SMWB $14.89
  • NUVB $8.17
  • AVG Volume (30 Days)
  • SMWB 524.2K
  • NUVB 6.8M
  • Earning Date
  • SMWB 11-11-2025
  • NUVB 11-05-2025
  • Dividend Yield
  • SMWB N/A
  • NUVB N/A
  • EPS Growth
  • SMWB N/A
  • NUVB N/A
  • EPS
  • SMWB N/A
  • NUVB N/A
  • Revenue
  • SMWB $268,346,999.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • SMWB $16.98
  • NUVB $332.80
  • Revenue Next Year
  • SMWB $14.91
  • NUVB $360.12
  • P/E Ratio
  • SMWB N/A
  • NUVB N/A
  • Revenue Growth
  • SMWB 16.06
  • NUVB 900.35
  • 52 Week Low
  • SMWB $6.36
  • NUVB $1.54
  • 52 Week High
  • SMWB $17.64
  • NUVB $4.09
  • Technical
  • Relative Strength Index (RSI)
  • SMWB 57.31
  • NUVB 56.26
  • Support Level
  • SMWB $9.59
  • NUVB $3.20
  • Resistance Level
  • SMWB $10.19
  • NUVB $3.41
  • Average True Range (ATR)
  • SMWB 0.43
  • NUVB 0.28
  • MACD
  • SMWB -0.06
  • NUVB -0.03
  • Stochastic Oscillator
  • SMWB 50.37
  • NUVB 29.04

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: